Our Clients

With LGM’s unique consultative approach, we are a trusted partner to our clients.

Our unique consultative approach makes LGM Pharma a trusted partner to our clients, supplying high quality APIs throughout the drug development cycle, while also assisting with logistics, regulatory compliance, technical documentation and lifecycle management. Our client base consists of a diverse array of pharmaceutical companies, including Biotech, Specialty Pharma/505(b)(2) and Drug Delivery Technology firms, among others


Here are just a few examples of projects LGM Pharma has supported:


Opertech Bio

Opertech Bio is a service-based business offering its customers a pioneering approach to measuring taste, covering the food and beverage, flavor ingredients, pet food, and pharmaceutical industries.
Learn More

InSitu Biologics

InSitu Biologics develops and produces implantable time release products composed of its proprietary and tunable bio-polymeric hydrogel, Matrix™.
Learn More

Orbis Biosciences, Inc.

Orbis Biosciences, Inc. provides controlled-release delivery technologies to create revolutionary pharmaceutical products that are safer and more effective than existing treatment options.
Learn More


CritiTech Particle Engineering Solutions (CT PES) is rapidly-growing, multi-service, pharmaceutical (CDMO) with expertise in particle engineering, material characterization, analytical testing, early-stage drug development and pre-clinical through clinical manufacturing.
Learn More


Illustris is a clinical-stage biodevelopment company whose objective is to reduce society’s exposure to potentially harmful active agents by utilizing our novel permeation technology to deliver active agents through tissue structures more
Learn More
Interested in discussing how LGM Pharma can support your project?

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service